These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23701167)

  • 1. Diagnosis of thyroid cancer: state of art.
    Boufraqech M; Patel D; Xiong Y; Kebebew E
    Expert Opin Med Diagn; 2013 Jul; 7(4):331-42. PubMed ID: 23701167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic markers and prognostic factors in thyroid cancer.
    Vriens MR; Schreinemakers JM; Suh I; Guerrero MA; Clark OH
    Future Oncol; 2009 Oct; 5(8):1283-93. PubMed ID: 19852742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
    Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
    Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the clinical application of thyroid cancer biomarkers.
    Shibru D; Chung KW; Kebebew E
    Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC; Cerutti JM
    Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.
    Keutgen XM; Filicori F; Fahey TJ
    Expert Rev Mol Diagn; 2013 Jul; 13(6):613-23. PubMed ID: 23895130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; McMillan A
    Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
    Eszlinger M; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma.
    Rodrigo JP; Rinaldo A; Devaney KO; Shaha AR; Ferlito A
    Head Neck; 2006 Nov; 28(11):1032-9. PubMed ID: 16732600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers.
    Nikiforov YE; Yip L; Nikiforova MN
    Clin Cancer Res; 2013 May; 19(9):2283-8. PubMed ID: 23422095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid carcinoma in children and adolescents: diagnostic implications of analysis of the tumor genome.
    Zimmerman D
    Curr Opin Pediatr; 2013 Aug; 25(4):528-31. PubMed ID: 23770925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
    Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
    Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous large-needle aspiration biopsy histology of palpable thyroid nodules: technical and diagnostic performance.
    Carpi A; Nicolini A; Marchetti C; Iervasi G; Antonelli A; Carpi F
    Histopathology; 2007 Aug; 51(2):249-57. PubMed ID: 17650219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating thyroid cancer markers.
    Gupta M; Chia SY
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle aspiration biopsy of thyroid nodules.
    Caplan RH; Strutt PJ; Kisken WA; Wester SM
    Wis Med J; 1991 Jun; 90(6):285-8. PubMed ID: 1871995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in predicting thyroid malignancy.
    Stang MT; Carty SE
    Curr Opin Oncol; 2009 Jan; 21(1):11-7. PubMed ID: 19125013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers in thyroid cancer diagnostics.
    Kato MA; Fahey TJ
    Surg Clin North Am; 2009 Oct; 89(5):1139-55. PubMed ID: 19836489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference.
    Baloch ZW; LiVolsi VA; Asa SL; Rosai J; Merino MJ; Randolph G; Vielh P; DeMay RM; Sidawy MK; Frable WJ
    Diagn Cytopathol; 2008 Jun; 36(6):425-37. PubMed ID: 18478609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules.
    Bohacek L; Milas M; Mitchell J; Siperstein A; Berber E
    Ann Surg Oncol; 2012 Jan; 19(1):45-51. PubMed ID: 21633868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.